Breaking
Wednesday, July 22, 2026

News

🌏 NMPA Page 12

Latest pharmaceutical news, drug approvals, and NMPA regulatory updates

Showing 133–144 of 248 articles

High impact NewsApr 29, 2026

Argo Biopharma Doses First Patient in Phase I Trial of siRNA Therapy BW-50218 for TTR-Related Disease

2 min

Sophie Martin
Critical impact NewsApr 29, 2026

Claruvis Pharmaceutical's Retoxin Becomes World's First Approved Recombinant Botulinum Toxin Type A in China

Dermatology/Aesthetics · 3 min

Sophie Martin
High impact NewsApr 29, 2026

Jyong Biotech Advances Market Access Strategy for Botanical Drug Botreso® and PCP Pipeline

2 min

Sophie Martin
High impact NewsApr 29, 2026

Arcera Life Sciences Partners with Fosun Pharma for Neurodegenerative Disease R&D Collaboration

2 min

Sophie Martin
High impact NewsApr 29, 2026

Samsung Bioepis Partners with ATLATL Innovation Center to Accelerate Asia-Pacific Biotech Development

2 min

Sophie Martin
High impact NewsApr 29, 2026

TGA Updates Comprehensive Regulatory Framework for Implantable Medical Devices in Australia

TGA · 2 min

Sophie Martin
High impact NewsApr 29, 2026

Immunic Appoints Dr. Michael Panzara as Chief Medical Officer to Lead Vidofludimus Calcium Development

2 min

Sophie Martin
High impact NewsApr 29, 2026

Zhengye Biotechnology Reports Fiscal 2025 Financial Results for Veterinary Vaccine Business

2 min

Sophie Martin
Critical impact NewsApr 29, 2026

ChinaBio Partnering Forum: Biotech Investment Trends Emerge

biotech · 8 min

Sophie Martin
High impact NewsApr 28, 2026

Akso Health Group Launches Brain-Computer Interface R&D Program Targeting Neurotechnology Market

Neurotechnology/Brain-Computer Interface · 3 min

Sophie Martin
High impact NewsApr 28, 2026

Evofem Biosciences Secures Exclusive SOLOSEC Distribution Agreement for Sub-Saharan Africa Market

2 min

Sophie Martin
High impact NewsApr 28, 2026

PSG 2026 Specialty Drug Benefits Report: Cost Management Remains Top Priority as Coverage Strategies Challenge Payers

2 min

Sophie Martin